BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, April 8, 2026
Home » Topics » Science » Biomarkers

Biomarkers
Biomarkers RSS Feed RSS

Biomarkers

TIPE2 is prognostic marker in colorectal cancer

Aug. 14, 2025
No Comments
Colorectal cancer is among the most common malignant tumor types and the second leading cause of tumor-related deaths worldwide. Tumor necrosis factor α-induced protein 8-like protein 2 (TIPE2) is a protein member of the TIPE family and highly expressed in immune cells. The prognostic impact and the relationship with tumor immunity of TIPE2 plus other immune markers such as CD8, CD20 and CD66b were evaluated in colorectal cancer by researchers from First Affiliated Hospital of Anhui Medical University and collaborators.
Read More
Illustration of triple-negative breast cancer cells
Cancer

SHCBP1 is triple-negative breast cancer driver, potential target

Aug. 12, 2025
No Comments
Triple-negative breast cancer (TNBC) accounts for a substantial proportion of all breast cancers and is the most aggressive form of the disease. Identifying potential therapeutic targets is critical because the cancer does not express the three surface receptors recognized by current targeted therapies.
Read More
3D rendering of prion structure

AI hacks disordered proteins

Aug. 5, 2025
By Mar de Miguel
No Comments
Deep learning tools for protein design can also be used to create molecules that bind to them. Certain peptides, such as intrinsically disordered proteins (IDPs), are challenging to target due to their variable nature. However, scientists from the lab of Nobel laureate David Baker have developed a method to generate binders for IDPs by searching the world’s largest protein database with their AI-powered tool RFdiffusion.
Read More
Art concept for medical research
Immune

SMPDL3B is new biomarker for myalgic encephalomyelitis

Aug. 4, 2025
No Comments
In a recent study in the Journal of Translational Medicine, researchers from Azrieli Research Center (Canada) and collaborating institutions hypothesized that the dysregulation of SMPDL3B may be involved in myalgic encephalomyelitis (ME) progression, and investigated its role and clinical relevance in ME pathophysiology.
Read More
3D rendering of prion structure
Drug design, drug delivery & technologies

AI hacks disordered proteins

Aug. 4, 2025
By Mar de Miguel
No Comments
Deep learning tools for protein design can also be used to create molecules that bind to them. Certain peptides, such as intrinsically disordered proteins (IDPs), are challenging to target due to their variable nature. However, scientists from the lab of Nobel laureate David Baker have developed a method to generate binders for IDPs by searching the world’s largest protein database with their AI-powered tool RFdiffusion.
Read More
Illustration of DNA composing the human body
Endocrine/metabolic

NBEA genetic variation is predictive of weight loss response with GLP-1 receptor agonists

July 31, 2025
No Comments
Researchers from the Cleveland Clinic and National Institutes of Health investigated the role of the neurobeachin (NBEA) gene in predicting weight loss response to glucagon-like peptide-1 receptor agonists.
Read More
Cancer

Phosphoglycerate kinase 1 is overexpressed in papillary thyroid carcinoma and linked with poor prognosis

July 31, 2025
No Comments
In a recent publication, researchers from The First Affiliated Hospital of Zhengzhou University (China) and collaborators investigated the association between phosphoglycerate kinase 1 (PGK1) expression in thyroid cancer tissues and clinicopathological features, postoperative recurrence and prognosis in papillary thyroid carcinoma (PTC). These observations may help advance clinical assessment and provide references for intervention strategies.
Read More
Medically accurate illustration of a baby in the womb of a pregnant mother
Neonatal/pediatrics

NrCAM as a predictor of fetal growth restriction

July 29, 2025
No Comments

Collaborators in Australia, South Africa, Sweden and the U.K. have linked reduced levels of neuronal cell adhesion molecule (NrCAM) in maternal or placental blood to greater risk of fetal growth restriction in newborns and of preeclampsia in the mothers, based on analysis of various cohorts of patients from several countries.


Read More
Cardiovascular

COMP as a potential early biomarker of thoracic aortic dissection

July 28, 2025
No Comments
Thoracic aortic dissection can progress to a highly lethal cardiac emergency, but it cannot usually be detected in early stages, so suitable biomarkers of progression are needed. Levels of C-reactive protein in serum rise during progression, but they also rise in infectious or autoimmune conditions, making the biomarker nonspecific.
Read More
Colorectal cancer illustration
Cancer

tRF-3021a impairs NK cell function via MICA cleavage, promoting immune escape in colorectal cancer

July 22, 2025
No Comments
Immune evasion continues to limit the effectiveness of cancer immunotherapies. Among emerging regulatory molecules, transfer RNA-derived small RNAs (tsRNAs of 13-48 nucleotides), generated through tRNA cleavage, are gaining attention for their roles in controlling gene expression at both the transcriptional and translational levels. Recent research suggests that abnormal tsRNA expression is closely associated with the development and progression of colorectal cancer.
Read More
Previous 1 2 3 4 5 6 7 8 9 10 … 268 269 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 8, 2026.
  • Cancer and blood cells

    Hematopoietic stem cell research points to leukemia’s early roots

    BioWorld Science
    Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
  • Hengrui discovers new Nav1.8 blockers

    BioWorld Science
    Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 7, 2026
  • 3D illustration of antibodies

    Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis

    BioWorld Science
    Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing